Open access
Open access
Powered by Google Translator Translator

Editor's Choice

RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.

22 Sep, 2022 | 13:20h | UTC

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)

Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine

News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health

 


Secondary analysis of a RCT | Complete revascularization vs. culprit lesion–only PCI for angina-related quality of life in patients with STEMI.

22 Sep, 2022 | 13:17h | UTC

Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Original Study: #ESCCongress – Randomized Trial: Complete Revascularization Superior to Culprit-lesion-only PCI in Patients with ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Coronary Artery Disease

Related meta-analysis:

Meta-analysis: multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease

Meta-Analysis: Complete vs. Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction

Study: Nonculprit-lesion PCI Timing in Patients With ST-Segment Elevation Myocardial Infarction

Studies in patients with cardiogenic shock:

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine

One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine

 


M-A of the association between new hypoglycemic agents and digestive diseases.

22 Sep, 2022 | 13:16h | UTC

Meta-analysis of the association between new hypoglycemic agents and digestive diseases – Medicine

Commentary: Spotlight on digestive risks of newer diabetes drugs – ACP Gastroenterology

 


RCT | Operative vs. nonoperative treatment of acute unstable chest wall injuries.

22 Sep, 2022 | 13:13h | UTC

Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)

Invited commentary: Operative Treatment of Acute Unstable Chest Wall Injuries—Let Us All Take a Deep Breath – JAMA Surgery (free for a limited period)

Author Interview: Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries – JAMA

Related:

Surgical management of rib fractures after blunt trauma: a systematic review and meta-analysis of randomised controlled trials – Annals of The Royal College of Surgeons of England

RCT | Rib fixation is not beneficial for non–ventilator-dependent chest wall injuries.

 

Commentary on Twitter

 


A quality improvement study showed that a clinic–based aspirin deimplementation intervention can reduce inappropriate aspirin prescribing and bleeding in patients receiving warfarin for anticoagulation.

22 Sep, 2022 | 13:14h | UTC

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation – JAMA Network Open

News Release: Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds – Michigan Medicine

 

Commentary on Twitter

 


RCT | Helmet noninvasive ventilation no better than usual respiratory support for acute hypoxemic respiratory failure due to COVID-19.

22 Sep, 2022 | 13:11h | UTC

Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial – JAMA

 

Commentary on Twitter

 


Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity.

22 Sep, 2022 | 13:09h | UTC

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity – Intensive Care Medicine

 

Commentary on Twitter

 


Study shows that the leading causes of hospitalization of adults with diabetes are changing.

22 Sep, 2022 | 13:08h | UTC

Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records – The Lancet Diabetes & Endocrinology

Commentaries:

The changing character of diabetes complications – The Lancet Diabetes & Endocrinology (free registration required)

Reasons for hospital admissions in people with type 2 diabetes are changing – MedicalXpress

 


Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.

21 Sep, 2022 | 13:21h | UTC

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized Trial – JACC: Cardiovascular Interventions

Commentaries:

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension – PADN-CFDA – American College of Cardiology

 

Commentary on Twitter

 


Guideline Synopsis | Management of major depressive disorder.

21 Sep, 2022 | 13:23h | UTC

The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline – Annals of Internal Medicine

 


ASCO Guideline | Integrative medicine for pain management in oncology.

21 Sep, 2022 | 13:22h | UTC

Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline – Journal of Clinical Oncology

Commentary: New SIO-ASCO practice guideline addresses the use of integrative therapies for cancer pain management – News Medical

 


Observational study suggests an increased risk of adverse events with the use of perioperative Gabapentin for pain management.

21 Sep, 2022 | 13:20h | UTC

Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery – JAMA Internal Medicine (free for a limited period)

Invited Commentary: Perioperative Gabapentin Use in Older Adults: Revisiting Multimodal Pain Management – JAMA Internal Medicine (free for a limited period)

 

Commentary on Twitter

 


M-A | Efficacy and safety of unrestricted visiting policy for critically ill patients.

21 Sep, 2022 | 13:18h | UTC

Efficacy and safety of unrestricted visiting policy for critically ill patients: a meta-analysis – Critical Care

 

Commentary on Twitter

https://twitter.com/arianna_gazzato/status/1568138556756860928

 


RCT | Effects of an exercise program on brain health outcomes for children with overweight or obesity.

21 Sep, 2022 | 13:17h | UTC

Effects of an Exercise Program on Brain Health Outcomes for Children With Overweight or Obesity: The ActiveBrains Randomized Clinical Trial – JAMA Network Open

News Release: Study finds schoolchildren who exercise perform better academically – University of Granada

Commentary: Exercise Improves Brain Health in Overweight, Obese Youth – HealthDay

 

Commentary on Twitter

 


Brief Review | Everything you need to know about deresuscitation.

21 Sep, 2022 | 13:19h | UTC

Everything you need to know about deresuscitation – Intensive Care Medicine

 

Commentary on Twitter

 


Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.

20 Sep, 2022 | 13:34h | UTC

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial – Circulation

Commentary: 10-Year Data From BEST Trial Find No Significant Safety or MACE Differences Between PCI With EES Versus CABG – Cardiac Interventions Today

Original Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine

 


Long-term follow-up of a RCT | Outcomes after catheter-based renal artery denervation for resistant hypertension.

20 Sep, 2022 | 13:33h | UTC

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial – The Lancet (free registration required)

Commentary: SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss – TCTMD

Original Study: A Controlled Trial of Renal Denervation for Resistant Hypertension – New England Journal of Medicine

 


RCT | Myopia control effect of repeated low-level red-light therapy in children.

20 Sep, 2022 | 13:31h | UTC

Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial – Ophthalmology

Commentary: Repeated Low-Level Red-Light Therapy Reduces Myopia Progression in Children – HCP Live

 


Brief Review | Source control in the management of sepsis and septic shock.

20 Sep, 2022 | 13:32h | UTC

Source control in the management of sepsis and septic shock – Intensive Care Medicine (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Preliminary results of a RCT | Once-only colonoscopy vs. two rounds of fecal immunochemical testing 2 years apart for colorectal cancer screening.

20 Sep, 2022 | 13:29h | UTC

Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

Commentary: Two Rounds of FIT vs Single Colonoscopy as a One-time CRC Screening – Medscape (free registration required)

 


Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.

20 Sep, 2022 | 13:30h | UTC

Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials – Frontiers in Cardiovascular Medicine

 


RCT | Cerebral embolic protection during transcatheter aortic-valve replacement did not significantly reduce the incidence of periprocedural stroke.

19 Sep, 2022 | 12:49h | UTC

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope – TCTMD

Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement – PROTECTED TAVR – American College of Cardiology

Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven — Large trial comes up short in proving a definitive benefit to debris filters – MedPage Today (free registration required)

News Release: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement – Cedars-Sinai

 

Commentary on Twitter

 


RCT | Multiple doses of prophylactic intravenous antibiotics are no better than a single dose in implant-based breast reconstruction.

19 Sep, 2022 | 12:48h | UTC

Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


Cohort Study | Seven healthy lifestyle habits linked to reduced risk of dementia in people with diabetes.

19 Sep, 2022 | 12:45h | UTC

Association of Combined Healthy Lifestyle Factors With Incident Dementia in Patients With Type 2 Diabetes – Neurology (link to abstract – $ for full-text)

News Release: Seven healthy lifestyle habits may reduce dementia risk for people with diabetes – American Academy of Neurology

Commentary: Lifestyle Factors May Cut Dementia Risk in Patients With Diabetes – HealthDay

 


Cluster RCT | Effects of real-time prescription benefit recommendations on patient out-of-pocket costs.

19 Sep, 2022 | 12:47h | UTC

Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)

Invited Commentary: Real-time Prescription Benefit Tools—The Promise and Peril – JAMA Internal Medicine (free for a limited period)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.